Chris Forbes

Chris Forbes has a diverse work experience spanning various roles and companies. In 2002, Chris started as a Research Associate at Bayer Pharmaceuticals and worked there until 2007. From 2007-2008, Chris worked as a Research Associate at RainDance Technologies and as an Internal Sales Associate at MetLife Investors. In 2008, Chris worked as a Support Specialist at Warner Instruments and as a Research Scientist at BioRelix. From 2012-2013, Chris served as a Senior Research Associate at Roche - 454. From 2013-2017, Chris worked at Alexion Pharmaceuticals, starting as a Research Associate III, then progressing to Research Associate IV and finally becoming a Scientist I. From 2017-2019, Chris worked as a Business Analyst at Core Informatics. Since 2019, Chris has been working at Halda Therapeutics, initially as a Research Investigator and then progressing to Principal Scientist, Associate Director, and currently serving as the Director of Biology, Profiling Lead.

Chris Forbes completed their education in a progressive manner. Starting in 1988, they attended Windsor Locks, although no degree or field of study is mentioned. From 1993 to 1996, they pursued a Bachelor's degree in Biology from the University of Connecticut. This was followed by a Master's degree in Health Physics from Texas A&M University, which they obtained between 1996 and 1999. Finally, Chris completed their education with a Master's degree in Pharmacology from Yale University, where they studied from 1999 to 2002.